Download PDF
Thromb Haemost 1992; 67(03): 386
DOI: 10.1055/s-0038-1648454
Letters to the Editor
Schattauer GmbH Stuttgart

Increased Levels of β2-Glycoprotein I (aca-Cofactor) in Patients with Lupus Anticoagulant

M Galli
Department of Haematology, Ospedali Riuniti, Bergamo, Italy
,
S Cortelazzo
Department of Haematology, Ospedali Riuniti, Bergamo, Italy
,
M Daldossi
Department of Haematology, Ospedali Riuniti, Bergamo, Italy
,
T Barbui
Department of Haematology, Ospedali Riuniti, Bergamo, Italy
› Author Affiliations
Further Information

Publication History

Received 07 September 1991

Accepted after revision 19 September 1991

Publication Date:
03 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Galli M, Comfurius P, Maassen C. et al Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; i: 1544-1547
    PubMedSearch in Google Scholar
  • 2 McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: p2-Glycoprotein I (Apolipo-protein H). Proc Natl Acad Sci USA 1990; 87: 4120-4124
    CrossrefPubMedSearch in Google Scholar
  • 3 Bevers EM, Galli M. p2-Glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; ii: 952-953
    PubMedSearch in Google Scholar
  • 4 Schousboe I. p2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 1985; 66: 1086-1091
    PubMedSearch in Google Scholar
  • 5 Schousboe I. Addition of deoxycholate in electroimmunoassay and crossed immunofocusing for quantification of p2-Glycoprotein I and its subfraction. J Biochem Biophys Methods 1982; 6: 105-114
    CrossrefPubMedSearch in Google Scholar